jueves, 6 de octubre de 2011

USA: Genéricos, una duda en el camino...

Generic prescription drugs saved U.S. consumers $931B over past decade

September 22, 2011 | Rene Letourneau, Managing Editor

WASHINGTON – Use of generic prescription drugs in the United States has saved consumers and the healthcare system $931 billion over the last 10 years, according to a new report from the Generic Pharmaceutical Association (GPhA).

In its recent report “Savings: An Economic Analysis of Generic Drug Usage in the U.S.,” the GPhA claims that in 2010 generic drug use generated nearly $158 billion in savings, an average of $3 billion every week. The report is based on independently conducted analysis, produced for GPhA by the IMS Institute for Healthcare Informatics and IMS Health. (Más)

A veces si...

• In 2010 alone, generic use generated more than $157 billion in savings.

• The Medicaid system could save more than $1.3 billion annually by increasing generic use by just two percentage points.

• Savings from newer generic medicines - those that have entered the market since 2001 - continue to increase exponentially and account for more than one-third of the total savings.

• Generic products for nervous system and cardiovascular treatments alone account for 62 percent of the cost savings.

• Despite having nearly seven times as many products on the market, generic medications still accounted for less drug spending than branded products with generic competition.

Over the past 10 years, patent settlements have resulted in billions of dollars in savings as dozens of first-time generics have come to market prior to patents expiring on the counterpart brand drugs.

A veces NO...
.


No hay comentarios: